



Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
FAT2 Double Nickase Plasmid (h) | sc-402931-NIC | 20 µg | $410.00 | |||
FAT2 Double Nickase Plasmid (h2) | sc-402931-NIC-2 | 20 µg | $410.00 |
FAT2 encodes an atypical cadherin-like transmembrane protein in the FAT protocadherin family that contributes to cell–cell adhesion and organization of epithelial architecture. Through its large extracellular cadherin repeats and intracellular signaling capacity, FAT2 is linked to regulation of cytoskeletal dynamics and planar cell polarity–associated processes that influence cell shape, migration, and tissue morphogenesis. Altered FAT family function has been associated with disrupted polarity and adhesion states that can affect differentiation programs and the balance between proliferation and contact inhibition. FAT2 has been explored in the context of cancer biology and developmental regulation where changes in adhesion signaling and polarity networks are relevant to disease mechanisms.
FAT2 Double Nickase Plasmid (h) consists of a matched pair of plasmids engineered for high-specificity editing of the FAT2 locus in human cell lines. Each plasmid expresses a Cas9 D10A nickase and a distinct sgRNA targeting opposite DNA strands within FAT2. When directed to adjacent sites on opposite DNA strands, the two nickases generate offset single-strand nicks that together produce a staggered double-strand break, requiring coordinated on-target activity from both guides. The resulting DNA break is resolved by endogenous cellular repair pathways, most commonly through non-homologous end joining (NHEJ), leading to insertions or deletions that disrupt FAT2 function. By requiring dual sgRNA engagement at the target locus, the double nicking approach enhances editing specificity and provides a complementary CRISPR strategy for applications where additional control over targeting precision is desired.
To support efficient identification of edited cells, one plasmid encodes GFP for fluorescent visualization of transfected populations, while the companion plasmid carries a puromycin resistance gene for antibiotic selection. Together, these features support efficient enrichment of co-transfected populations and simplify the validation of FAT2-disrupted clones.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.